About Infallible Pharma Private Limited
Data last updated:
Infallible Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2019PTC322834. Its GSTIN is 27AAFCI2186P1ZZ (Maharashtra). The company holds 5 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.44 Cr. It is led by directors including Hari Om (Managing Director) and Shreekant Krishna Shetty (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 202 2nd Floor Matru Smruti Building Lokmanylak Road No. 02 Dadar East, Mumbai, Maharashtra, India – 400014.
As per the financials filed for FY 2025, the company reported a revenue of ₹106.73 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹10.67 Lakh (net margin 0.1%) and EBITDA of ₹3.37 Cr (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 111% over five years.
The company has about 69 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Infallible Pharma. As per MCA filings, the company has open charges of ₹36.95 Cr and satisfied charges of ₹8 Cr on record.
For more details, the company can be reached via its website infalliblepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address202 2nd Floor Matru Smruti Building Lokmanylak Road No. 02 Dadar East, Mumbai, Maharashtra, India – 400014
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Infallible Pharma Private Limited
Infallible Pharma operates one associated brand: Infallible Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| R&D company manufacturing drugs for multiple therapeutic areas | infalliblepharma.com |
Business Activity of Infallible Pharma Private Limited
The main business activity of Infallible Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Infallible Pharma Private Limited
Infallible Pharma Private Limited is audited by ROHIT J VISHWAKARMA for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ROHIT J VISHWAKARMA | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Infallible Pharma Private Limited
Infallible Pharma has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shreekant Krishna Shetty Also directs: Mckesson & Robbins Private Limited, Amerisourcebergen Private Limited, Sagent Pharmaceuticals Private Limited and 2 more | Whole-Time Director | 01 Sep 2019 | 7 Years 1 Months | Current |
| Hari Om Also directs: Mckesson & Robbins Private Limited, Amerisourcebergen Private Limited, Sagent Pharmaceuticals Private Limited and 3 more | Managing Director | 20 Mar 2019 | 7 Years 6 Months | Current |
| Hari Krishnababu Naidu | Director | 16 Dec 2024 | 1 Years 9 Months | Current |
Financials of Infallible Pharma Private Limited FY 2025 filings available
Infallible Pharma Private Limited reported revenue of ₹106.73 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Infallible Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 111% over five years, including 3% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Infallible Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.37 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹10.67 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Infallible Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Infallible Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Infallible Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Infallible Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Aug 2024 | Others | ₹8 Cr | Open |
| 24 Nov 2023 | Others | ₹7.5 Cr | Open |
| 26 Aug 2021 | Others | ₹21.45 Cr | Open |
| 27 Oct 2022 | Others | ₹8 Cr | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Infallible Pharma Private Limited
Infallible Pharma Private Limited has a workforce of 69 employees as of Mar 23, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Infallible Pharma Private Limited
Infallible Pharma has 5 GST registrations: 2 active and 3 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCI2186P1ZZ | Maharashtra | Active | 23 May 2019 |
| 02AAFCI2186P1ZB | Himachal Pradesh | Active | 04 Oct 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Infallible Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Infallible Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Infallible Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Infallible Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Infallible Pharma Private Limited
Frequently Asked Questions about Infallible Pharma Private Limited
Infallible Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 March 2019 (7+ years old) and is registered under CIN U24304MH2019PTC322834.
Infallible Pharma reported revenue of ₹106.73 Cr for FY 2025 (up 3% YoY).
Infallible Pharma has 3 current directors:
- Hari Om - Managing Director
- Shreekant Krishna Shetty - Whole-Time Director
- Hari Krishnababu Naidu - Director
Infallible Pharma reported a net profit of ₹10.67 Lakh (net margin 0.1%) and EBITDA of ₹3.37 Cr (EBITDA margin 3.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Infallible Pharma is -9% over three years and 111% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Infallible Pharma is 27AAFCI2186P1ZZ, registered in Maharashtra. The company has 5 GST registrations in all, of which 2 are active and 3 are cancelled or inactive. Other active GSTINs include 02AAFCI2186P1ZB (Himachal Pradesh).
The CIN (Corporate Identification Number) of Infallible Pharma is U24304MH2019PTC322834. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Infallible Pharma was incorporated on 20 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Yes, Infallible Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).